The 600sqft suite will enable the conjugation of high-potency active pharmaceutical ingredients (HPAPIs) to a variety of targeted delivery molecules, including monoclonal antibodies. In addition, the new facility
WuXi will maintain its original plan to construct, own and operate a 323,450sqft good laboratory practice (GLP) facility in Suzhou, China which is slated to open in the
Takeda Global R&D Centre Europe (TGRD EU) submitted the marketing authorization application (MAA) for ramelteon in Europe in March 2007. The Committee for Medicinal Products for Human Use
Clinically tested in France, Breathe Again is said to be 100% natural, combining the benefits of pure seawater and the drying effect of a hypertonic solution. According to
MediCult has entered into a share purchase agreement with Terry Fortino, president and majority shareholder of MidAtlantic Diagnostics, to purchase the entire issued share capital for an up-front
The new reactor is the latest in a series of investments designed to enhance production capacity and expand capabilities at the Arklow site, which is the company’s global
The Committee for Medicinal Products for Human Use’s (CHMP’s) positive opinion is now referred for final action to the European Commission, which grants approval in the EU. The
The additional data showed that Triolex is safe and well tolerated to date, and that it significantly improved insulin sensitivity and lowered fasting blood glucose and insulin levels
Mr Kennedy was most recently a member of senior management and an executive director of Cozart, a medical diagnostics company specializing in drugs-of-abuse testing in the UK and
Previously, Ipsen has exclusively in-licensed from Debiopharm know-how and new patent applications for the commercialization rights of the new six-month formulation of Decapeptyl in the world excluding North
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.